Consistently, we have demonstrated that TSA treatment can prevent the manifestation of T1D in NOD mice, associated with histone H3 hyperacetylation, and selective up-regulation of genes encoding CD4+ T-cell-derived lymphokine, Ifng and its transcription factor, Tbet/Tbx21[8]. This evidence concerns the gene IFNG and type 1 diabetes mellitus.